View Clinical Trial (Medical Research Study)
Improving Osteoporosis Care in High-Risk Home Health Patients - NCT00679198-35294(Clinical Trial 221246)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Birmingham |
|
State:
|
|
AL |
| Zip Code: |
|
35294 |
| Conditions: |
|
Patient Compliance - Communication - Osteoporosis - Fractures, Bone |
| Purpose: |
|
SPECIFIC AIMS: We propose a three-year study to develop a high-intensity intervention to
improve osteoporosis care and test a novel intervention in a group-randomized trial of 27
home health offices and 1,000 patients referred to home health care with a history of
fracture.
Aim 1. Develop an intervention to promote osteoporosis treatment that includes: (1) training
to enhance nurse-patient and nurse-physician risk communication regarding osteoporosis and
fracture risk; (2) automated prompts within the home health agency's electronic medical
record system to promote appropriate osteoporosis management; and (3) implementation of
osteoporosis-related standardized care pathways and order sets.
Aim 2. Conduct a group-randomized trial to test the effectiveness of the intervention to
promote initial use of osteoporosis medications and adherence to treatment after discharge
from home health. We hypothesize that:
H1: Patients in the intervention group will have increased initial receipt of osteoporosis
prescription medications and calcium/vitamin D supplements to prevent and treat osteoporosis
compared to patients receiving usual care; H2: Patients in the intervention group will
demonstrate increased persistence in the use of these therapies compared to those receiving
usual care.
Secondary Aims (SA) will include exploratory analyses of fracture related morbidity and
mortality, patient-reported quality of life, and health services utilization and costs.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Patients will be identified as "at-risk" if they are referred to home health care for
post-fracture care or if they are admitted for another reason and have a previous
diagnosis of fracture.
Exclusion Criteria:
- Patients in hospice, with a life expectancy < 1 year, over 95 years old, or with
concomitant metabolic bone diseases (e.g. Paget's disease of bone) will be excluded. |
|
|
|
| Study is available at: |
|
University of Alabama at Birmingham Department of Rheumatology
Birmingham, AL 35294
United States
Primary Contact:
Meredith L Kilgore, PhD RN
Email: MKilgore@ms.soph.uab.edu
Secondary Contact:
Meredith L Kilgore, PhD RN
Email: MKilgore@ms.soph.uab.edu
Phone: (205) 975-8840 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 22, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|